Latest Data of InnoCares Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 08, 2025 21:04 ET Â | Source: InnoCare Pharma BEIJING, Dec. 08,…
NOTICE TO DISREGARD — ICARO Media Group
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- We are advised by…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET Â | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear…
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET Â | Source: Cerevance, Inc. Phase 2 results…
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
December 05, 2025 17:00 ET Â | Source: Rocket Doctor AI Inc. Vancouver,…
Elekta showcases Evo, its AI-powered, online adaptive CT-Linac at the Association of Medical Physicists of India – National Congress 2025 (AMPICON) in Guwahati
Evo features high-definition image quality and online adaptive radiotherapy capabilities for treating…
Kia EV5 WKNDR Spontaneous Escape Enabler Debuts at Guangzhou Auto Show
EV5 WKNDR created by Kia Design China team for a global audienceConcept…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2025 08:00 ET Â | Source: UroGen Pharma Ltd. PRINCETON, N.J.,…
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease
December 05, 2025 08:00 ET Â | Source: Amneal Pharmaceuticals LLC Interim data…